↓ Skip to main content

DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer

Overview of attention for article published in BMC Cancer, December 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
24 Mendeley